Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database have?

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database has 182 citations in the OpenAlex counts ScholarIQ stores.

When was Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database published?

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database has 2022 year in the ScholarIQ index.

What is the open-access status of Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database?

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database has gold oa status in the ScholarIQ index.

What is the DOI of Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database?

The DOI for Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database is on the source record.

What is the PMID of Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database?

The PMID for Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database is on the source record.

What is the OpenAlex record for Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database?

The OpenAlex for Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database is on the source record.